FLC-VOLARA-ACUTE-CARE
The Volara System: Oscillation & Lung Expansion Therapy (OLE)
Explore The Volara System: Oscillation & Lung Expansion (OLE) Therapy from Hillrom, a machine that combines 3 respiratory therapies to help you breathe easier.
ACTIVE
ACTIVE
true
false
false
false
false
https://assets.hillrom.com/is/image/hillrom/Volara_Controller_3-4L_No-Handle_No-Claw_startup-screen?$recentlyViewedProducts$
Request More Information
false
hillrom:care-category/non-invasive-respiratory-therapy
hillrom:sub-category/therapy-oscillation-lung-expansion,hillrom:care-setting/acute-care,hillrom:care-setting/hospital-to-home,hillrom:sub-category/clearance-airway,hillrom:care-category/non-invasive-respiratory-therapy

The Volara System: Oscillation & Lung Expansion Therapy (OLE)

The Volara system can make it faster and easier to deliver oscillation & lung expansion (OLE) therapy to a broader range of patients throughout the hospital — and even at home.

 

Find a Distributor

Looking for a Welch Allyn distributor? Find our list here. For other product families, fill out the form below.

3-in-1 Therapy1

Oscillation and Lung Expansion therapy (OLE) has shown to deliver positive clinical outcomes and potential economic savings in the acute care setting.1

volara centrella mask

 

Deliver timely, clinically studied Oscillation and Lung Expansion (OLE) therapy in just ten minutes with the Volara System from Baxter.

The system uses alternating cycles of Continuous Positive Expiratory Pressure (CPEP) and Continuous High Frequency Oscillation (CHFO), combined with aerosol delivery, to help your patients get more value from their OLE therapy.

CPEP

Continuous Positive Expiratory Pressure treats and helps prevent pulmonary atelectasis by combining continuous positive pressure with aerosol medication, to help expand and hold the airways open.

CHFO

Continuous High Frequency Oscillation, a pneumatic form of chest therapy, delivers continuous pulses of positive pressure combined with aerosol medication to mobilize and treat retained secretions.

Nebulizer

Integrated with CPEP and CHFO, medication is delivered during therapy to help loosen secretions.

volara stage on monitor screen
volara progressa mask on patient by nurse in hospital bed

The Volara System gives you the versatility to deliver airway clearance to patients in multiple hospital settings, with features including a wide therapeutic pressure range to treat a wide range of patients, programmable therapy presets for standardization across patient groups and enhanced device mobility for use throughout the hospital.

Designed For Precision

With a wide pressure range that allows you to treat a broad range of patients, it accommodates multiple delivery modes, including tracheostomy, mask, mouthpiece and in-line with a ventilator.

Patient circuit features ergonomic handle, multiple interfaces and nebulizer delivery.

volara mouthpiece, mask and tracheostomy pieces

Help More Patients Breathe Easy

The Volara System makes OLE therapy practical and accessible for patients across a variety of acute care settings. And when they’re discharged, they can continue their OLE therapy at home, using your settings and protocols.

Patients Conditions Departments
Acute Pneumonia Bronchiectasis Emergency
Chronic Post-Op Pulmonary Complications Cystic fibrosis Department
Trauma COPD Spinal Cord Intensive Care
Post-op Trauma Injury Gen Med/Surgery
Geriatric Neuro Stroke  
Bariatric Pediatrics Transplant Pediatric

For further information about VOLARA System, please contact your Baxter sales representative or call Baxter customer service at 1-800-267-2337.

Technical Specifications

Dig deeper into product attributes to see how we can fit your requirements.

Device Height (w/o stand) 26.9 cm
Device Width (w/o stand) 23.3 cm
Device weight (w/o stand) 4.98 kg
Device depth (w/o) stand 22.3 cm

Product Information

Get in the know to get the most value out of your solution.

  • Videos

    keyboard_arrow_down
  • Brochures

    keyboard_arrow_down
    Icon to download brochure
    VOLARA System Acute Clinician Brochure

Clinically Proven Therapy for Patients Hospital-Wide1,2

Tested and proven in acute care settings, OLE therapy has been shown to provide positive clinical outcomes.

A 419-patient, two-phase multicenter study1 showed that pulmonary treatment with OLE therapy, along with standard respiratory therapy, reduced the rate of certain PPCs in high-risk surgical patients who underwent thoracic, upper abdominal or aortic open surgical procedures.

Read the full clinical study summary here.

Frequently Asked Questions

For the safe and proper use of the devices referenced within, refer to intended use, warnings, precautions, and complete instructions for use or the appropriate manual.

References:

1. Clinical Network Survey. September 10, 2018. n=44. Data on file.
2. Hillrom. (2022). OLE: A Guide to Clinical Outcomes (206762 rev 3). St. Paul, MN.
3. Huynh TT, Liesching TN, Cereda M, et al. Efficacy of Oscillation and Lung Expansion in Reducing Postoperative Pulmonary Complication. J Am Coll Surg. 2019;229(5):458-466.e1.doi:10.1016/j.jamcollsurg.2019.06.004.
4. Nyland B, Spilman S, Halub M, et al. A preventative respiratory protocol to identify trauma subjects at risk for respiratory compromise on a general in-patient ward. Respir Care. 2016. doi:10.4187/respcare.04729.

Baxter, Hillrom, Smart-Filter and Volara are trademarks of Baxter International Inc. or its subsidiaries.
FLC200-250002